News for OptiBiotix Health Plc (OPTI.L)

Published at

Jan 15, 2024 11:42 AM

by marketscreener.com

neutral

neutral

OptiBiotix's LeanBiome to be launched under MuscleTech

OptiBiotix Health PLC on Monday announced the launch of LeanBiome in sports nutrition brand, MuscleTech. The York, England-based life sciences company said LeanBiome will be incorporated in...

OPTI.L

Read more →
Published at

Dec 18, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Prebiotics Ingredients Global Market to Observe Impressive Growth at a CAGR of ~10% by 2028 | DelveInsight

The prebiotic ingredients market is experiencing noteworthy growth, propelled by various factors such as the increasing demand for prebiotics as a key...

PHAT OPTI.L MDGS.TA MDGS JNJ HOCPY HOCPF DOW DJNJ3.BA DJNJ2.BA ASH 7741N.MX 7741.T 2OY.DE FCG.NZ DOW1.MX D1OW34.SA 195940.KQ KYGAN.MX KYGA.L KRZ.IR KRYAY KRYAF 000075.KS 000070.KS

Read more →
Published at

Oct 23, 2023 11:18 AM

by marketscreener.com

positive

positive

OptiBiotix adds Tata Chemicals ingredient to obesity product in India

OptiBiotix Health PLC on Monday said it agreed a licence deal with Tata Chemicals Ltd to incorporate Tata's short-chain fructo-oligosaccharide Fossence into OptiBiotix's SlimBiome and LeanBiome...

OPTI.L

Read more →
Published at

Oct 12, 2023 8:02 AM

by marketscreener.com

positive

positive

Net Asset Value(s)

Net Asset Value Seneca Growth Capital VCT Plc 12 October 2023 Net Asset Value Update for the period ended 30 September 2023 The Directors and the Investment Manager of the Company, Seneca...

VEL.L SCNLF SCLP.L SBTX.L OPTI.L OBD.L HYG.L AREC.L

Read more →
Published at

Oct 12, 2023 8:00 AM

by globenewswire.com

positive

positive

Net Asset Value(s)

Net Asset Value(s) Seneca Growth Capital VCT Plc (the “Company”) 12 October 2023 Net Asset Value (“NAV”) Update for the period ended 30 September 2023 ...

VEL.L SCNLF SCLP.L SBTX.L OPTI.L OBD.L HYG.L AREC.L

Read more →
Published at

Aug 14, 2023 12:21 PM

by globenewswire.com

mixed

mixed

Live Biotherapeutic Product (LBP) Market is Riding the Wave of Growth and Expected to Grow at a CAGR of 21.2 % to 2031 | Reveals Latest InsightAce Study

Companies covered in this report are Seres Therapeutics, Inc., Microbiotica, Enterome, Destiny Pharma plc, Taisho Pharmaceutical Holdings, AOBiome...

MCRB IMRNW IMRN IMC.AX FNCH EVLO DEST.L PTCHF PRTC.L PRTC OPTI.L KLDO

Read more →
Published at

Aug 2, 2023 12:00 PM

by globenewswire.com

mixed

mixed

Prebiotics Market Set to Hit USD 10,435.16 Million By 2030, Says Reports Insights

Prebiotics Market projected to expand at 7.1% CAGR (2023-2030), valued at USD 10,435.16 million by 2030 from USD 6,065.16 million in 2022. Pharma's role...

OPTI.L KHNZ.DE KHC.MX KHC

Read more →
Published at

Jun 10, 2023 12:15 AM

by prnewswire.com

mixed

mixed

Global Human Microbiome Market Report 2023: Sector is Projected to Reach $1.7 Billion by 2029 at a CAGR of 36.1%

/PRNewswire/ -- The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer,...

LBPSW LBPS FRPRF FNCH DDDD.L SYBX OPTI.L MCRB IFFT IFF 0A8U.L

Read more →
Published at

May 26, 2023 7:00 PM

by prnewswire.com

mixed

mixed

Human Microbiome Market worth $1.7 billion | MarketsandMarkets

/PRNewswire/ -- The human microbiome industry is poised for exponential growth and transformative advancements in the near future. As our understanding of the...

OPTI.L LBPS SYBX MCRB LBPSW IFFT IFF FRPRF FNCH DDDD.L 0A8U.L

Read more →
Published at

Feb 23, 2023 12:10 PM

by globenewswire.com

mixed

mixed

Digestive Health Market Size ($104.4 Bn by 2032 at 8.2% CAGR) Globally, Analysis by Market.us

According to Market.us, the global digestive health market is estimated to be valued at USD 104.4 billion by 2032 and is expected to exhibit a CAGR of 8.2%...

OPTI.L MLWEL.PA MLKRI.PA MLAHC.PA YKLTY PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MLMAD.PA HLF GSK.L GSK GS7.DE GLAXF BFFAF BASN.MX BASFY BASF.MI BASF.BD BASA.DE BAS.DE 2267.T

Read more →
Published at

Jul 7, 2022 11:00 AM

by prnewswire.com

mixed

mixed

Live Biotherapeutic Product (LBP) Market worth $ 2.60 billion by 2030 - Exclusive Report by InsightAce Analytic

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Live Biotherapeutic Product (LBP) Market...

LBPS MCRB IMRNW IMRN IMC.AX FNCH EVLO DEST.L PTCHF PRTC.L PRTC OPTI.L LBPSW KLDO FRPRF DDDD.L

Read more →
Published at

Sep 30, 2021 8:12 AM

by marketscreener.com

mixed

mixed

OptiBiotix Health : Results Report

all for LPLDL®/CholBiome®. These agreements have been reached to build LP LDL® and CholBiome's reputation and brand awareness in Asia and open up the potential for cross boarder e-commerce... | September 30, 2021

SNIRF SBTX.L OPTI.L 006490.KS

Read more →